Led by founder and CEO Chad Bouton, Neuvotion develops AI-guided brain-body interface technologies for neurorecovery, including non-invasive stimulation platforms and minimally invasive brain-computer interfaces. The company combines medical-device development experience with clinical expertise in spinal cord injury, stroke, rehabilitation, and neurosurgery to pursue technologies that can help restore movement and independence.
BioMotion LLCBioMotion LLC develops intelligent neurorehabilitation systems, beginning with Adaptix Neuro, an AI-enabled stationary cycling platform that adjusts therapy in real time for people with Parkinson’s disease. The company grew from more than 15 years of peer-reviewed research in motor-assisted cycling and brings together control-systems engineers, clinical researchers, and medical-device innovators. Its interdisciplinary founding team includes Kent State exercise physiologist Angela Ridgel and Case Western Reserve University control expert Kenneth Loparo.CLEVELAND, OH
NeuroVirtFounded by neuroscientist Dr. Eve Gregoriou during their PhD at University College London, NeuroVirt develops mixed-reality neurorehabilitation technology that turns upper- and lower-limb therapy into measurable, gamified movement practice. Its platform combines immersive exercises with motion tracking, AI-enabled feedback, and a clinician-facing WebApp for use in clinics or at home. NeuroVirt’s patient-centred system has been co-designed with more than 500 patients and 350 clinicians, including participants in multi-site stroke rehabilitation studies.BROOKLYN, NY
Precision NeuroscienceCo-founded by neurosurgeon and electrical engineer Benjamin Rapoport, Precision Neuroscience brings clinical experience directly into the development of brain–computer interfaces. The company makes its Layer 7 cortical interface in-house at a 22,000-square-foot MEMS fabrication facility in Addison, Texas, with an initial focus on helping people with paralysis operate digital devices through thought.
Control BionicsFor more than two decades, Control Bionics has built its identity around EMG science and the practical challenge of giving people access to communication and measurable physical recovery. The company develops non-invasive neural-signal technology for people with complex physical needs, as well as for clinicians and researchers working to understand neuromuscular activity. Its platform is cleared by the FDA, TGA, and CE and is deployed internationally.MILFORD, OH